Cargando…
The use of glucocorticoids in marmoset wasting syndrome
BACKGROUND: Marmoset wasting syndrome (MWS) is one of the leading causes of morbidity and mortality in captive marmosets, and thus far no reliable treatment has been found. Glucocorticoids are used widely to treat inflammatory conditions of the GI tract such as human and feline inflammatory bowel di...
Autores principales: | Otovic, Pete, Smith, Shanequa, Hutchinson, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415595/ https://www.ncbi.nlm.nih.gov/pubmed/25614344 http://dx.doi.org/10.1111/jmp.12159 |
Ejemplares similares
-
The profile of lipid metabolites in urine of marmoset wasting syndrome
por: Yamazaki, Arisa, et al.
Publicado: (2020) -
Reduced differentiation of intestinal epithelial cells in wasting marmoset syndrome
por: NIIMI, Kimie, et al.
Publicado: (2021) -
Serum matrix metalloproteinase 9 (MMP9) as a biochemical marker for wasting
marmoset syndrome
por: YOSHIMOTO, Takuro, et al.
Publicado: (2016) -
Marmoset prosociality is intentional
por: Burkart, Judith M., et al.
Publicado: (2020) -
Measurement of the α1-proteinase inhibitor (α1-antitrypsin) of common marmoset and intestinal protein loss in wasting syndrome
por: Niimi, Kimie, et al.
Publicado: (2019)